- Central European Biotechnology Portal
be visible on the BioBusiness market                  ISSN 2300-0228
Most popular

All articles

Show search box
Mabion targets Bosnia

Mabion targets Bosnia

Mabion SA submitted in Bosnia full set of R&D and legal documents in order to register clinical trials of MabionCD20 medicine, which is used in therapy of blood cancers and rheumatoid arthritis (RA). The application was delivered to 6 bioethical commissions in Bosnia and in the Council of Registratio... Read more
Tags poland , pharma , europe , bosnia